Global Gene Therapy Products Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Gene Therapy Products Industry Forecast” looks at past sales and reviews total world Gene Therapy Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Therapy Products sales for 2023 through 2029. With Gene Therapy Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy Products industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Therapy Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Gene Therapy Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy Products and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy Products.
The global Gene Therapy Products market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene Therapy Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene Therapy Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene Therapy Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene Therapy Products players cover Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc. and Advantagene, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy Products market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Gene Therapy Products market?
What factors are driving Gene Therapy Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gene Therapy Products market opportunities vary by end market size?
How does Gene Therapy Products break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Gene Therapy Products Industry Forecast” looks at past sales and reviews total world Gene Therapy Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Therapy Products sales for 2023 through 2029. With Gene Therapy Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy Products industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Therapy Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Gene Therapy Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy Products and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy Products.
The global Gene Therapy Products market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene Therapy Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene Therapy Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene Therapy Products is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene Therapy Products players cover Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc. and Advantagene, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy Products market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Ex vivo
- In Vivo
- Cancer
- Monogenic
- Infectious disease
- Cardiovascular disease
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bluebird Bio
- Sangamo
- Spark Therapeutics
- Dimension Therapeutics
- Avalanche Bio
- Celladon
- Vical Inc.
- Advantagene
What is the 10-year outlook for the global Gene Therapy Products market?
What factors are driving Gene Therapy Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gene Therapy Products market opportunities vary by end market size?
How does Gene Therapy Products break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy Products Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Gene Therapy Products by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Gene Therapy Products by Country/Region, 2018, 2022 & 2029
2.2 Gene Therapy Products Segment by Type
2.2.1 Ex vivo
2.2.2 In Vivo
2.3 Gene Therapy Products Sales by Type
2.3.1 Global Gene Therapy Products Sales Market Share by Type (2018-2023)
2.3.2 Global Gene Therapy Products Revenue and Market Share by Type (2018-2023)
2.3.3 Global Gene Therapy Products Sale Price by Type (2018-2023)
2.4 Gene Therapy Products Segment by Application
2.4.1 Cancer
2.4.2 Monogenic
2.4.3 Infectious disease
2.4.4 Cardiovascular disease
2.4.5 Other
2.5 Gene Therapy Products Sales by Application
2.5.1 Global Gene Therapy Products Sale Market Share by Application (2018-2023)
2.5.2 Global Gene Therapy Products Revenue and Market Share by Application (2018-2023)
2.5.3 Global Gene Therapy Products Sale Price by Application (2018-2023)
3 GLOBAL GENE THERAPY PRODUCTS BY COMPANY
3.1 Global Gene Therapy Products Breakdown Data by Company
3.1.1 Global Gene Therapy Products Annual Sales by Company (2018-2023)
3.1.2 Global Gene Therapy Products Sales Market Share by Company (2018-2023)
3.2 Global Gene Therapy Products Annual Revenue by Company (2018-2023)
3.2.1 Global Gene Therapy Products Revenue by Company (2018-2023)
3.2.2 Global Gene Therapy Products Revenue Market Share by Company (2018-2023)
3.3 Global Gene Therapy Products Sale Price by Company
3.4 Key Manufacturers Gene Therapy Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gene Therapy Products Product Location Distribution
3.4.2 Players Gene Therapy Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GENE THERAPY PRODUCTS BY GEOGRAPHIC REGION
4.1 World Historic Gene Therapy Products Market Size by Geographic Region (2018-2023)
4.1.1 Global Gene Therapy Products Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Gene Therapy Products Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Gene Therapy Products Market Size by Country/Region (2018-2023)
4.2.1 Global Gene Therapy Products Annual Sales by Country/Region (2018-2023)
4.2.2 Global Gene Therapy Products Annual Revenue by Country/Region (2018-2023)
4.3 Americas Gene Therapy Products Sales Growth
4.4 APAC Gene Therapy Products Sales Growth
4.5 Europe Gene Therapy Products Sales Growth
4.6 Middle East & Africa Gene Therapy Products Sales Growth
5 AMERICAS
5.1 Americas Gene Therapy Products Sales by Country
5.1.1 Americas Gene Therapy Products Sales by Country (2018-2023)
5.1.2 Americas Gene Therapy Products Revenue by Country (2018-2023)
5.2 Americas Gene Therapy Products Sales by Type
5.3 Americas Gene Therapy Products Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy Products Sales by Region
6.1.1 APAC Gene Therapy Products Sales by Region (2018-2023)
6.1.2 APAC Gene Therapy Products Revenue by Region (2018-2023)
6.2 APAC Gene Therapy Products Sales by Type
6.3 APAC Gene Therapy Products Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gene Therapy Products by Country
7.1.1 Europe Gene Therapy Products Sales by Country (2018-2023)
7.1.2 Europe Gene Therapy Products Revenue by Country (2018-2023)
7.2 Europe Gene Therapy Products Sales by Type
7.3 Europe Gene Therapy Products Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy Products by Country
8.1.1 Middle East & Africa Gene Therapy Products Sales by Country (2018-2023)
8.1.2 Middle East & Africa Gene Therapy Products Revenue by Country (2018-2023)
8.2 Middle East & Africa Gene Therapy Products Sales by Type
8.3 Middle East & Africa Gene Therapy Products Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gene Therapy Products
10.3 Manufacturing Process Analysis of Gene Therapy Products
10.4 Industry Chain Structure of Gene Therapy Products
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gene Therapy Products Distributors
11.3 Gene Therapy Products Customer
12 WORLD FORECAST REVIEW FOR GENE THERAPY PRODUCTS BY GEOGRAPHIC REGION
12.1 Global Gene Therapy Products Market Size Forecast by Region
12.1.1 Global Gene Therapy Products Forecast by Region (2024-2029)
12.1.2 Global Gene Therapy Products Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gene Therapy Products Forecast by Type
12.7 Global Gene Therapy Products Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bluebird Bio
13.1.1 Bluebird Bio Company Information
13.1.2 Bluebird Bio Gene Therapy Products Product Portfolios and Specifications
13.1.3 Bluebird Bio Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bluebird Bio Main Business Overview
13.1.5 Bluebird Bio Latest Developments
13.2 Sangamo
13.2.1 Sangamo Company Information
13.2.2 Sangamo Gene Therapy Products Product Portfolios and Specifications
13.2.3 Sangamo Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sangamo Main Business Overview
13.2.5 Sangamo Latest Developments
13.3 Spark Therapeutics
13.3.1 Spark Therapeutics Company Information
13.3.2 Spark Therapeutics Gene Therapy Products Product Portfolios and Specifications
13.3.3 Spark Therapeutics Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Spark Therapeutics Main Business Overview
13.3.5 Spark Therapeutics Latest Developments
13.4 Dimension Therapeutics
13.4.1 Dimension Therapeutics Company Information
13.4.2 Dimension Therapeutics Gene Therapy Products Product Portfolios and Specifications
13.4.3 Dimension Therapeutics Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Dimension Therapeutics Main Business Overview
13.4.5 Dimension Therapeutics Latest Developments
13.5 Avalanche Bio
13.5.1 Avalanche Bio Company Information
13.5.2 Avalanche Bio Gene Therapy Products Product Portfolios and Specifications
13.5.3 Avalanche Bio Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Avalanche Bio Main Business Overview
13.5.5 Avalanche Bio Latest Developments
13.6 Celladon
13.6.1 Celladon Company Information
13.6.2 Celladon Gene Therapy Products Product Portfolios and Specifications
13.6.3 Celladon Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Celladon Main Business Overview
13.6.5 Celladon Latest Developments
13.7 Vical Inc.
13.7.1 Vical Inc. Company Information
13.7.2 Vical Inc. Gene Therapy Products Product Portfolios and Specifications
13.7.3 Vical Inc. Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Vical Inc. Main Business Overview
13.7.5 Vical Inc. Latest Developments
13.8 Advantagene
13.8.1 Advantagene Company Information
13.8.2 Advantagene Gene Therapy Products Product Portfolios and Specifications
13.8.3 Advantagene Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Advantagene Main Business Overview
13.8.5 Advantagene Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy Products Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Gene Therapy Products by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Gene Therapy Products by Country/Region, 2018, 2022 & 2029
2.2 Gene Therapy Products Segment by Type
2.2.1 Ex vivo
2.2.2 In Vivo
2.3 Gene Therapy Products Sales by Type
2.3.1 Global Gene Therapy Products Sales Market Share by Type (2018-2023)
2.3.2 Global Gene Therapy Products Revenue and Market Share by Type (2018-2023)
2.3.3 Global Gene Therapy Products Sale Price by Type (2018-2023)
2.4 Gene Therapy Products Segment by Application
2.4.1 Cancer
2.4.2 Monogenic
2.4.3 Infectious disease
2.4.4 Cardiovascular disease
2.4.5 Other
2.5 Gene Therapy Products Sales by Application
2.5.1 Global Gene Therapy Products Sale Market Share by Application (2018-2023)
2.5.2 Global Gene Therapy Products Revenue and Market Share by Application (2018-2023)
2.5.3 Global Gene Therapy Products Sale Price by Application (2018-2023)
3 GLOBAL GENE THERAPY PRODUCTS BY COMPANY
3.1 Global Gene Therapy Products Breakdown Data by Company
3.1.1 Global Gene Therapy Products Annual Sales by Company (2018-2023)
3.1.2 Global Gene Therapy Products Sales Market Share by Company (2018-2023)
3.2 Global Gene Therapy Products Annual Revenue by Company (2018-2023)
3.2.1 Global Gene Therapy Products Revenue by Company (2018-2023)
3.2.2 Global Gene Therapy Products Revenue Market Share by Company (2018-2023)
3.3 Global Gene Therapy Products Sale Price by Company
3.4 Key Manufacturers Gene Therapy Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gene Therapy Products Product Location Distribution
3.4.2 Players Gene Therapy Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GENE THERAPY PRODUCTS BY GEOGRAPHIC REGION
4.1 World Historic Gene Therapy Products Market Size by Geographic Region (2018-2023)
4.1.1 Global Gene Therapy Products Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Gene Therapy Products Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Gene Therapy Products Market Size by Country/Region (2018-2023)
4.2.1 Global Gene Therapy Products Annual Sales by Country/Region (2018-2023)
4.2.2 Global Gene Therapy Products Annual Revenue by Country/Region (2018-2023)
4.3 Americas Gene Therapy Products Sales Growth
4.4 APAC Gene Therapy Products Sales Growth
4.5 Europe Gene Therapy Products Sales Growth
4.6 Middle East & Africa Gene Therapy Products Sales Growth
5 AMERICAS
5.1 Americas Gene Therapy Products Sales by Country
5.1.1 Americas Gene Therapy Products Sales by Country (2018-2023)
5.1.2 Americas Gene Therapy Products Revenue by Country (2018-2023)
5.2 Americas Gene Therapy Products Sales by Type
5.3 Americas Gene Therapy Products Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy Products Sales by Region
6.1.1 APAC Gene Therapy Products Sales by Region (2018-2023)
6.1.2 APAC Gene Therapy Products Revenue by Region (2018-2023)
6.2 APAC Gene Therapy Products Sales by Type
6.3 APAC Gene Therapy Products Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gene Therapy Products by Country
7.1.1 Europe Gene Therapy Products Sales by Country (2018-2023)
7.1.2 Europe Gene Therapy Products Revenue by Country (2018-2023)
7.2 Europe Gene Therapy Products Sales by Type
7.3 Europe Gene Therapy Products Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy Products by Country
8.1.1 Middle East & Africa Gene Therapy Products Sales by Country (2018-2023)
8.1.2 Middle East & Africa Gene Therapy Products Revenue by Country (2018-2023)
8.2 Middle East & Africa Gene Therapy Products Sales by Type
8.3 Middle East & Africa Gene Therapy Products Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gene Therapy Products
10.3 Manufacturing Process Analysis of Gene Therapy Products
10.4 Industry Chain Structure of Gene Therapy Products
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gene Therapy Products Distributors
11.3 Gene Therapy Products Customer
12 WORLD FORECAST REVIEW FOR GENE THERAPY PRODUCTS BY GEOGRAPHIC REGION
12.1 Global Gene Therapy Products Market Size Forecast by Region
12.1.1 Global Gene Therapy Products Forecast by Region (2024-2029)
12.1.2 Global Gene Therapy Products Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gene Therapy Products Forecast by Type
12.7 Global Gene Therapy Products Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bluebird Bio
13.1.1 Bluebird Bio Company Information
13.1.2 Bluebird Bio Gene Therapy Products Product Portfolios and Specifications
13.1.3 Bluebird Bio Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bluebird Bio Main Business Overview
13.1.5 Bluebird Bio Latest Developments
13.2 Sangamo
13.2.1 Sangamo Company Information
13.2.2 Sangamo Gene Therapy Products Product Portfolios and Specifications
13.2.3 Sangamo Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sangamo Main Business Overview
13.2.5 Sangamo Latest Developments
13.3 Spark Therapeutics
13.3.1 Spark Therapeutics Company Information
13.3.2 Spark Therapeutics Gene Therapy Products Product Portfolios and Specifications
13.3.3 Spark Therapeutics Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Spark Therapeutics Main Business Overview
13.3.5 Spark Therapeutics Latest Developments
13.4 Dimension Therapeutics
13.4.1 Dimension Therapeutics Company Information
13.4.2 Dimension Therapeutics Gene Therapy Products Product Portfolios and Specifications
13.4.3 Dimension Therapeutics Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Dimension Therapeutics Main Business Overview
13.4.5 Dimension Therapeutics Latest Developments
13.5 Avalanche Bio
13.5.1 Avalanche Bio Company Information
13.5.2 Avalanche Bio Gene Therapy Products Product Portfolios and Specifications
13.5.3 Avalanche Bio Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Avalanche Bio Main Business Overview
13.5.5 Avalanche Bio Latest Developments
13.6 Celladon
13.6.1 Celladon Company Information
13.6.2 Celladon Gene Therapy Products Product Portfolios and Specifications
13.6.3 Celladon Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Celladon Main Business Overview
13.6.5 Celladon Latest Developments
13.7 Vical Inc.
13.7.1 Vical Inc. Company Information
13.7.2 Vical Inc. Gene Therapy Products Product Portfolios and Specifications
13.7.3 Vical Inc. Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Vical Inc. Main Business Overview
13.7.5 Vical Inc. Latest Developments
13.8 Advantagene
13.8.1 Advantagene Company Information
13.8.2 Advantagene Gene Therapy Products Product Portfolios and Specifications
13.8.3 Advantagene Gene Therapy Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Advantagene Main Business Overview
13.8.5 Advantagene Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Therapy Products Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Gene Therapy Products Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Ex vivo
Table 4. Major Players of In Vivo
Table 5. Global Gene Therapy Products Sales by Type (2018-2023) & (K Units)
Table 6. Global Gene Therapy Products Sales Market Share by Type (2018-2023)
Table 7. Global Gene Therapy Products Revenue by Type (2018-2023) & ($ million)
Table 8. Global Gene Therapy Products Revenue Market Share by Type (2018-2023)
Table 9. Global Gene Therapy Products Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Gene Therapy Products Sales by Application (2018-2023) & (K Units)
Table 11. Global Gene Therapy Products Sales Market Share by Application (2018-2023)
Table 12. Global Gene Therapy Products Revenue by Application (2018-2023)
Table 13. Global Gene Therapy Products Revenue Market Share by Application (2018-2023)
Table 14. Global Gene Therapy Products Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Gene Therapy Products Sales by Company (2018-2023) & (K Units)
Table 16. Global Gene Therapy Products Sales Market Share by Company (2018-2023)
Table 17. Global Gene Therapy Products Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Gene Therapy Products Revenue Market Share by Company (2018-2023)
Table 19. Global Gene Therapy Products Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Gene Therapy Products Producing Area Distribution and Sales Area
Table 21. Players Gene Therapy Products Products Offered
Table 22. Gene Therapy Products Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Gene Therapy Products Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Gene Therapy Products Sales Market Share Geographic Region (2018-2023)
Table 27. Global Gene Therapy Products Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Gene Therapy Products Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Gene Therapy Products Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Gene Therapy Products Sales Market Share by Country/Region (2018-2023)
Table 31. Global Gene Therapy Products Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Gene Therapy Products Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Gene Therapy Products Sales by Country (2018-2023) & (K Units)
Table 34. Americas Gene Therapy Products Sales Market Share by Country (2018-2023)
Table 35. Americas Gene Therapy Products Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Gene Therapy Products Revenue Market Share by Country (2018-2023)
Table 37. Americas Gene Therapy Products Sales by Type (2018-2023) & (K Units)
Table 38. Americas Gene Therapy Products Sales by Application (2018-2023) & (K Units)
Table 39. APAC Gene Therapy Products Sales by Region (2018-2023) & (K Units)
Table 40. APAC Gene Therapy Products Sales Market Share by Region (2018-2023)
Table 41. APAC Gene Therapy Products Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Gene Therapy Products Revenue Market Share by Region (2018-2023)
Table 43. APAC Gene Therapy Products Sales by Type (2018-2023) & (K Units)
Table 44. APAC Gene Therapy Products Sales by Application (2018-2023) & (K Units)
Table 45. Europe Gene Therapy Products Sales by Country (2018-2023) & (K Units)
Table 46. Europe Gene Therapy Products Sales Market Share by Country (2018-2023)
Table 47. Europe Gene Therapy Products Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Gene Therapy Products Revenue Market Share by Country (2018-2023)
Table 49. Europe Gene Therapy Products Sales by Type (2018-2023) & (K Units)
Table 50. Europe Gene Therapy Products Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Gene Therapy Products Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Gene Therapy Products Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Gene Therapy Products Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Gene Therapy Products Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Gene Therapy Products Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Gene Therapy Products Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Gene Therapy Products
Table 58. Key Market Challenges & Risks of Gene Therapy Products
Table 59. Key Industry Trends of Gene Therapy Products
Table 60. Gene Therapy Products Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Gene Therapy Products Distributors List
Table 63. Gene Therapy Products Customer List
Table 64. Global Gene Therapy Products Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Gene Therapy Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Gene Therapy Products Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Gene Therapy Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Gene Therapy Products Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Gene Therapy Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Gene Therapy Products Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Gene Therapy Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Gene Therapy Products Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Gene Therapy Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Gene Therapy Products Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Gene Therapy Products Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Gene Therapy Products Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Gene Therapy Products Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Bluebird Bio Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 79. Bluebird Bio Gene Therapy Products Product Portfolios and Specifications
Table 80. Bluebird Bio Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Bluebird Bio Main Business
Table 82. Bluebird Bio Latest Developments
Table 83. Sangamo Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 84. Sangamo Gene Therapy Products Product Portfolios and Specifications
Table 85. Sangamo Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Sangamo Main Business
Table 87. Sangamo Latest Developments
Table 88. Spark Therapeutics Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 89. Spark Therapeutics Gene Therapy Products Product Portfolios and Specifications
Table 90. Spark Therapeutics Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Spark Therapeutics Main Business
Table 92. Spark Therapeutics Latest Developments
Table 93. Dimension Therapeutics Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 94. Dimension Therapeutics Gene Therapy Products Product Portfolios and Specifications
Table 95. Dimension Therapeutics Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Dimension Therapeutics Main Business
Table 97. Dimension Therapeutics Latest Developments
Table 98. Avalanche Bio Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 99. Avalanche Bio Gene Therapy Products Product Portfolios and Specifications
Table 100. Avalanche Bio Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Avalanche Bio Main Business
Table 102. Avalanche Bio Latest Developments
Table 103. Celladon Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 104. Celladon Gene Therapy Products Product Portfolios and Specifications
Table 105. Celladon Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Celladon Main Business
Table 107. Celladon Latest Developments
Table 108. Vical Inc. Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 109. Vical Inc. Gene Therapy Products Product Portfolios and Specifications
Table 110. Vical Inc. Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Vical Inc. Main Business
Table 112. Vical Inc. Latest Developments
Table 113. Advantagene Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 114. Advantagene Gene Therapy Products Product Portfolios and Specifications
Table 115. Advantagene Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Advantagene Main Business
Table 117. Advantagene Latest Developments
Table 1. Gene Therapy Products Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Gene Therapy Products Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Ex vivo
Table 4. Major Players of In Vivo
Table 5. Global Gene Therapy Products Sales by Type (2018-2023) & (K Units)
Table 6. Global Gene Therapy Products Sales Market Share by Type (2018-2023)
Table 7. Global Gene Therapy Products Revenue by Type (2018-2023) & ($ million)
Table 8. Global Gene Therapy Products Revenue Market Share by Type (2018-2023)
Table 9. Global Gene Therapy Products Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Gene Therapy Products Sales by Application (2018-2023) & (K Units)
Table 11. Global Gene Therapy Products Sales Market Share by Application (2018-2023)
Table 12. Global Gene Therapy Products Revenue by Application (2018-2023)
Table 13. Global Gene Therapy Products Revenue Market Share by Application (2018-2023)
Table 14. Global Gene Therapy Products Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Gene Therapy Products Sales by Company (2018-2023) & (K Units)
Table 16. Global Gene Therapy Products Sales Market Share by Company (2018-2023)
Table 17. Global Gene Therapy Products Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Gene Therapy Products Revenue Market Share by Company (2018-2023)
Table 19. Global Gene Therapy Products Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Gene Therapy Products Producing Area Distribution and Sales Area
Table 21. Players Gene Therapy Products Products Offered
Table 22. Gene Therapy Products Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Gene Therapy Products Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Gene Therapy Products Sales Market Share Geographic Region (2018-2023)
Table 27. Global Gene Therapy Products Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Gene Therapy Products Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Gene Therapy Products Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Gene Therapy Products Sales Market Share by Country/Region (2018-2023)
Table 31. Global Gene Therapy Products Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Gene Therapy Products Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Gene Therapy Products Sales by Country (2018-2023) & (K Units)
Table 34. Americas Gene Therapy Products Sales Market Share by Country (2018-2023)
Table 35. Americas Gene Therapy Products Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Gene Therapy Products Revenue Market Share by Country (2018-2023)
Table 37. Americas Gene Therapy Products Sales by Type (2018-2023) & (K Units)
Table 38. Americas Gene Therapy Products Sales by Application (2018-2023) & (K Units)
Table 39. APAC Gene Therapy Products Sales by Region (2018-2023) & (K Units)
Table 40. APAC Gene Therapy Products Sales Market Share by Region (2018-2023)
Table 41. APAC Gene Therapy Products Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Gene Therapy Products Revenue Market Share by Region (2018-2023)
Table 43. APAC Gene Therapy Products Sales by Type (2018-2023) & (K Units)
Table 44. APAC Gene Therapy Products Sales by Application (2018-2023) & (K Units)
Table 45. Europe Gene Therapy Products Sales by Country (2018-2023) & (K Units)
Table 46. Europe Gene Therapy Products Sales Market Share by Country (2018-2023)
Table 47. Europe Gene Therapy Products Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Gene Therapy Products Revenue Market Share by Country (2018-2023)
Table 49. Europe Gene Therapy Products Sales by Type (2018-2023) & (K Units)
Table 50. Europe Gene Therapy Products Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Gene Therapy Products Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Gene Therapy Products Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Gene Therapy Products Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Gene Therapy Products Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Gene Therapy Products Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Gene Therapy Products Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Gene Therapy Products
Table 58. Key Market Challenges & Risks of Gene Therapy Products
Table 59. Key Industry Trends of Gene Therapy Products
Table 60. Gene Therapy Products Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Gene Therapy Products Distributors List
Table 63. Gene Therapy Products Customer List
Table 64. Global Gene Therapy Products Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Gene Therapy Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Gene Therapy Products Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Gene Therapy Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Gene Therapy Products Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Gene Therapy Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Gene Therapy Products Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Gene Therapy Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Gene Therapy Products Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Gene Therapy Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Gene Therapy Products Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Gene Therapy Products Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Gene Therapy Products Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Gene Therapy Products Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Bluebird Bio Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 79. Bluebird Bio Gene Therapy Products Product Portfolios and Specifications
Table 80. Bluebird Bio Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Bluebird Bio Main Business
Table 82. Bluebird Bio Latest Developments
Table 83. Sangamo Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 84. Sangamo Gene Therapy Products Product Portfolios and Specifications
Table 85. Sangamo Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Sangamo Main Business
Table 87. Sangamo Latest Developments
Table 88. Spark Therapeutics Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 89. Spark Therapeutics Gene Therapy Products Product Portfolios and Specifications
Table 90. Spark Therapeutics Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Spark Therapeutics Main Business
Table 92. Spark Therapeutics Latest Developments
Table 93. Dimension Therapeutics Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 94. Dimension Therapeutics Gene Therapy Products Product Portfolios and Specifications
Table 95. Dimension Therapeutics Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Dimension Therapeutics Main Business
Table 97. Dimension Therapeutics Latest Developments
Table 98. Avalanche Bio Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 99. Avalanche Bio Gene Therapy Products Product Portfolios and Specifications
Table 100. Avalanche Bio Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Avalanche Bio Main Business
Table 102. Avalanche Bio Latest Developments
Table 103. Celladon Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 104. Celladon Gene Therapy Products Product Portfolios and Specifications
Table 105. Celladon Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Celladon Main Business
Table 107. Celladon Latest Developments
Table 108. Vical Inc. Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 109. Vical Inc. Gene Therapy Products Product Portfolios and Specifications
Table 110. Vical Inc. Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Vical Inc. Main Business
Table 112. Vical Inc. Latest Developments
Table 113. Advantagene Basic Information, Gene Therapy Products Manufacturing Base, Sales Area and Its Competitors
Table 114. Advantagene Gene Therapy Products Product Portfolios and Specifications
Table 115. Advantagene Gene Therapy Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Advantagene Main Business
Table 117. Advantagene Latest Developments
LIST OF FIGURES
Figure 1. Picture of Gene Therapy Products
Figure 2. Gene Therapy Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gene Therapy Products Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Gene Therapy Products Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Gene Therapy Products Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Ex vivo
Figure 10. Product Picture of In Vivo
Figure 11. Global Gene Therapy Products Sales Market Share by Type in 2022
Figure 12. Global Gene Therapy Products Revenue Market Share by Type (2018-2023)
Figure 13. Gene Therapy Products Consumed in Cancer
Figure 14. Global Gene Therapy Products Market: Cancer (2018-2023) & (K Units)
Figure 15. Gene Therapy Products Consumed in Monogenic
Figure 16. Global Gene Therapy Products Market: Monogenic (2018-2023) & (K Units)
Figure 17. Gene Therapy Products Consumed in Infectious disease
Figure 18. Global Gene Therapy Products Market: Infectious disease (2018-2023) & (K Units)
Figure 19. Gene Therapy Products Consumed in Cardiovascular disease
Figure 20. Global Gene Therapy Products Market: Cardiovascular disease (2018-2023) & (K Units)
Figure 21. Gene Therapy Products Consumed in Other
Figure 22. Global Gene Therapy Products Market: Other (2018-2023) & (K Units)
Figure 23. Global Gene Therapy Products Sales Market Share by Application (2022)
Figure 24. Global Gene Therapy Products Revenue Market Share by Application in 2022
Figure 25. Gene Therapy Products Sales Market by Company in 2022 (K Units)
Figure 26. Global Gene Therapy Products Sales Market Share by Company in 2022
Figure 27. Gene Therapy Products Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Gene Therapy Products Revenue Market Share by Company in 2022
Figure 29. Global Gene Therapy Products Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Gene Therapy Products Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Gene Therapy Products Sales 2018-2023 (K Units)
Figure 32. Americas Gene Therapy Products Revenue 2018-2023 ($ Millions)
Figure 33. APAC Gene Therapy Products Sales 2018-2023 (K Units)
Figure 34. APAC Gene Therapy Products Revenue 2018-2023 ($ Millions)
Figure 35. Europe Gene Therapy Products Sales 2018-2023 (K Units)
Figure 36. Europe Gene Therapy Products Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Gene Therapy Products Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Gene Therapy Products Revenue 2018-2023 ($ Millions)
Figure 39. Americas Gene Therapy Products Sales Market Share by Country in 2022
Figure 40. Americas Gene Therapy Products Revenue Market Share by Country in 2022
Figure 41. Americas Gene Therapy Products Sales Market Share by Type (2018-2023)
Figure 42. Americas Gene Therapy Products Sales Market Share by Application (2018-2023)
Figure 43. United States Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Gene Therapy Products Sales Market Share by Region in 2022
Figure 48. APAC Gene Therapy Products Revenue Market Share by Regions in 2022
Figure 49. APAC Gene Therapy Products Sales Market Share by Type (2018-2023)
Figure 50. APAC Gene Therapy Products Sales Market Share by Application (2018-2023)
Figure 51. China Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Gene Therapy Products Sales Market Share by Country in 2022
Figure 59. Europe Gene Therapy Products Revenue Market Share by Country in 2022
Figure 60. Europe Gene Therapy Products Sales Market Share by Type (2018-2023)
Figure 61. Europe Gene Therapy Products Sales Market Share by Application (2018-2023)
Figure 62. Germany Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Gene Therapy Products Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Gene Therapy Products Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Gene Therapy Products Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Gene Therapy Products Sales Market Share by Application (2018-2023)
Figure 71. Egypt Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Gene Therapy Products in 2022
Figure 77. Manufacturing Process Analysis of Gene Therapy Products
Figure 78. Industry Chain Structure of Gene Therapy Products
Figure 79. Channels of Distribution
Figure 80. Global Gene Therapy Products Sales Market Forecast by Region (2024-2029)
Figure 81. Global Gene Therapy Products Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Gene Therapy Products Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Gene Therapy Products Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Gene Therapy Products Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Gene Therapy Products Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Gene Therapy Products
Figure 2. Gene Therapy Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gene Therapy Products Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Gene Therapy Products Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Gene Therapy Products Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Ex vivo
Figure 10. Product Picture of In Vivo
Figure 11. Global Gene Therapy Products Sales Market Share by Type in 2022
Figure 12. Global Gene Therapy Products Revenue Market Share by Type (2018-2023)
Figure 13. Gene Therapy Products Consumed in Cancer
Figure 14. Global Gene Therapy Products Market: Cancer (2018-2023) & (K Units)
Figure 15. Gene Therapy Products Consumed in Monogenic
Figure 16. Global Gene Therapy Products Market: Monogenic (2018-2023) & (K Units)
Figure 17. Gene Therapy Products Consumed in Infectious disease
Figure 18. Global Gene Therapy Products Market: Infectious disease (2018-2023) & (K Units)
Figure 19. Gene Therapy Products Consumed in Cardiovascular disease
Figure 20. Global Gene Therapy Products Market: Cardiovascular disease (2018-2023) & (K Units)
Figure 21. Gene Therapy Products Consumed in Other
Figure 22. Global Gene Therapy Products Market: Other (2018-2023) & (K Units)
Figure 23. Global Gene Therapy Products Sales Market Share by Application (2022)
Figure 24. Global Gene Therapy Products Revenue Market Share by Application in 2022
Figure 25. Gene Therapy Products Sales Market by Company in 2022 (K Units)
Figure 26. Global Gene Therapy Products Sales Market Share by Company in 2022
Figure 27. Gene Therapy Products Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Gene Therapy Products Revenue Market Share by Company in 2022
Figure 29. Global Gene Therapy Products Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Gene Therapy Products Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Gene Therapy Products Sales 2018-2023 (K Units)
Figure 32. Americas Gene Therapy Products Revenue 2018-2023 ($ Millions)
Figure 33. APAC Gene Therapy Products Sales 2018-2023 (K Units)
Figure 34. APAC Gene Therapy Products Revenue 2018-2023 ($ Millions)
Figure 35. Europe Gene Therapy Products Sales 2018-2023 (K Units)
Figure 36. Europe Gene Therapy Products Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Gene Therapy Products Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Gene Therapy Products Revenue 2018-2023 ($ Millions)
Figure 39. Americas Gene Therapy Products Sales Market Share by Country in 2022
Figure 40. Americas Gene Therapy Products Revenue Market Share by Country in 2022
Figure 41. Americas Gene Therapy Products Sales Market Share by Type (2018-2023)
Figure 42. Americas Gene Therapy Products Sales Market Share by Application (2018-2023)
Figure 43. United States Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Gene Therapy Products Sales Market Share by Region in 2022
Figure 48. APAC Gene Therapy Products Revenue Market Share by Regions in 2022
Figure 49. APAC Gene Therapy Products Sales Market Share by Type (2018-2023)
Figure 50. APAC Gene Therapy Products Sales Market Share by Application (2018-2023)
Figure 51. China Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Gene Therapy Products Sales Market Share by Country in 2022
Figure 59. Europe Gene Therapy Products Revenue Market Share by Country in 2022
Figure 60. Europe Gene Therapy Products Sales Market Share by Type (2018-2023)
Figure 61. Europe Gene Therapy Products Sales Market Share by Application (2018-2023)
Figure 62. Germany Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Gene Therapy Products Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Gene Therapy Products Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Gene Therapy Products Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Gene Therapy Products Sales Market Share by Application (2018-2023)
Figure 71. Egypt Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Gene Therapy Products Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Gene Therapy Products in 2022
Figure 77. Manufacturing Process Analysis of Gene Therapy Products
Figure 78. Industry Chain Structure of Gene Therapy Products
Figure 79. Channels of Distribution
Figure 80. Global Gene Therapy Products Sales Market Forecast by Region (2024-2029)
Figure 81. Global Gene Therapy Products Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Gene Therapy Products Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Gene Therapy Products Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Gene Therapy Products Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Gene Therapy Products Revenue Market Share Forecast by Application (2024-2029)
